Lasa Supergenerics
LASA · Pharma > Pharmaceuticals & Drugs · Chairman: Omkar Herlekar · MD: Omkar Herlekar · Listing date: Sept. 22, 2017 · Employees: 194 · Mumbai · http://lasalabs.com

Stock Price vs Company Growth
1d
1.6%
1w
5.9%
1m
13.0%
3m
18.0%
6m
27.6%
1y
61.0%
5y
34.3%
all
27.7%

Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price

₹ 10.2 1.6%
9.2
14.1
Company Overview

Sales
95.3 Cr
Growth: 2.5%
Profit after Tax
-44.4 Cr
Growth: 7.3%
Micro Cap
50.9 Cr
P/S: 0.5x
Industry P/S: 2.5x
Fundamentals

Sales (Cr) ₹ 95.3
Growth 2.5%
EBITDA -0.3%
P/S 0.5x
Dividend 0.0%
P/E -1.4x
Book Value ₹ 9.45
PEG Ratio -0.6x
ROE -67.1%
P/B 1.1x
Shareholding Pattern

Institutions
Promoters
Omkar Pravin Herlekar
64.47 %
Others
Bebi Dharma Padhir
2.82 %
Anil Vishanji Dedhia
1.76 %
Increase    Decrease    No change
Company Profile Detailed

The company is specialises in ‘catalyst chemistry’ and manufactures anthelmintic/ veterinary API products with the largest production capabilities and product categories in IndiaProduct CategoriesVeterinary API ProductsOther API ProductsAnimal Feed IngredientsReagents For Therapeutic Use
Investors (19)
Followers (3)